US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Aerospace & Commercial Aviation ETF

25.29

+0.02420.10%

Post-market: 25.290.00000.00%16:10 EDT

Volume:783

Turnover:19.84K

Market Cap:758.70K

PE:- -

High:25.38

Open:25.38

Low:25.28

Close:25.27

52wk High:29.72

52wk Low:25.04

Shares:30.00K

Float Shares:30.00K

Volume Ratio:1.01

T/O Rate:2.61%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Skyward Group Expands ibott’s Next-Generation Autonomous Vehicle Solutions Into U.S. Primary Market

Global Public Display and Signage TV Shipments Surpass 1.73 Million Units in Q2, IFP/Touch Screens Lead Growth

Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Beamr Launches ML-Safe Lossless Compression for Autonomous Vehicle Fleets

Aviva plc (AV) Gets a Hold from Barclays

Beamr to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months

Citi Remains a Hold on Aviva plc (AV)

Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions

AV Concept Holdings Allocates HK$1.294 Million for Share Buyback on August 24

Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)

Chairman and Executive Director Su Yujun Boosts Stake in AV Concept Holdings with 2.176 Million Share Purchase

AV Concept Holdings Allocates HK$2.58 Million to Buy Back 2 Million Shares on August 20

Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results

Australian Clinical Labs Leads Our ASX Penny Stock Picks

Simply Wall St.

Uber's Expansion with AV Partners Seen Boosting Confidence

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/AV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AV\",,,,,undefined,":{"symbol":"AV","market":"US","secType":"STK","nameCN":"Corgi Aerospace & Commercial Aviation ETF","latestPrice":25.2901,"timestamp":1790971200000,"preClose":25.2659,"halted":0,"volume":783,"hourTrading":{"tag":"盘后","latestPrice":25.2901,"preClose":25.2901,"latestTime":"16:10 EDT","volume":6,"amount":151.720404,"timestamp":1790971804448,"change":0,"changeRate":0,"amplitude":0.000399},"delay":0,"changeRate":0.000957812704079429,"floatShares":30000,"shares":30000,"eps":0,"marketStatus":"Post-Mkt","change":0.0242,"latestTime":"10-02 18:09:39 EDT","open":25.38,"high":25.3805,"low":25.28,"amount":19841,"amplitude":0.003978,"askPrice":37.93,"askSize":200,"bidPrice":12.65,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1256011200000,"exchange":"CBOE","adjPreClose":25.2659,"nav":25.17,"aum":755100,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.2901,"preClose":25.2901,"latestTime":"16:10 EDT","volume":6,"amount":151.720404,"timestamp":1790971804448,"change":0,"changeRate":0,"amplitude":0.000399},"volumeRatio":1.011367,"impliedVol":0.0847,"impliedVolPercentile":0.6947},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AV\",,,,,undefined,":{"symbol":"AV","floatShares":30000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.011367,"shares":30000,"dividePrice":0,"high":25.3805,"amplitude":0.003978,"preClose":25.2659,"low":25.28,"week52Low":25.0435,"pbRate":"--","week52High":29.72,"institutionHeld":0.0846,"latestPrice":25.2901,"eps":0,"divideRate":0,"volume":783,"delay":0,"ttmEps":0,"open":25.38,"prevYearClose":26.42,"prevWeekClose":25.8886,"prevMonthClose":25.2291,"prevQuarterClose":25.2291,"fiveDayClose":25.8886,"twentyDayClose":26.8112,"sixtyDayClose":28.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AV\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671936202","title":"Skyward Group Expands ibott’s Next-Generation Autonomous Vehicle Solutions Into U.S. Primary Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2671936202","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671936202?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:30","pubTimestamp":1790771400,"startTime":"0","endTime":"0","summary":"Expansion combines ibott’s deep AV and digital-economy expertise with the breadth and capabilities of Skyward Group to deliver more complete solutions for emerging mobility risksHOUSTON, Sept.  30, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371878/0/en/skyward-group-expands-ibott-s-next-generation-autonomous-vehicle-solutions-into-u-s-primary-market.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177762221","title":"Global Public Display and Signage TV Shipments Surpass 1.73 Million Units in Q2, IFP/Touch Screens Lead Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1177762221","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177762221?lang=en_us&edition=fundamental","pubTime":"2026-09-30 11:26","pubTimestamp":1790738781,"startTime":"0","endTime":"0","summary":"Omdia's latest Public Display Market Tracker research shows that global public display and signage TV shipments exceeded 1.73 million units in the second quarter of 2026, up from 1.61 million units...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV","AIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232406","title":"Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232406","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232406?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:00","pubTimestamp":1790596800,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., Sept.  28, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369816/0/en/humacyte-expands-board-expertise-with-appointment-of-scott-coward-and-paul-kuznik.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669934134","title":"Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2669934134","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669934134?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":"Montreal Heart Institute Joins Multinational Study Evaluating a Self-Administered 70 mg Repeat-Dose Regimen of EtripamilMONTREAL and CHARLOTTE, N.C., Sept.  24, 2026 (GLOBE NEWSWIRE) -- Milestone Phar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368250/0/en/milestone-pharmaceuticals-enrolls-first-canadian-study-participant-in-revera-301-phase-3-pivotal-trial-evaluating-etripamil-nasal-spray-for-afib-rvr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VR","IDNA","BK4129","MEDX","BK4585","LU1559883803.SGD","NVIB","LU0566484027.USD","GDOC","HYLG","AV","ECG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667989369","title":"Beamr Launches ML-Safe Lossless Compression for Autonomous Vehicle Fleets","url":"https://stock-news.laohu8.com/highlight/detail?id=2667989369","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667989369?lang=en_us&edition=fundamental","pubTime":"2026-09-16 21:27","pubTimestamp":1789565220,"startTime":"0","endTime":"0","summary":"Autonomous vehicle test fleets generate more video than they can store or move. Beamr’s lossless compression keeps footage bit-exact at capture in the test vehicles, while reducing file sizes by 47%. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/16/3363266/0/en/beamr-launches-ml-safe-lossless-compression-for-autonomous-vehicle-fleets.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","AV","CABR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667584601","title":"Aviva plc (AV) Gets a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2667584601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667584601?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:16","pubTimestamp":1789550161,"startTime":"0","endTime":"0","summary":"In a report released today, Ivan Bokhmat from Barclays maintained a Hold rating on Aviva plc, with a price target of £7.16. Bokhmat covers the Fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/aviva-plc-av-gets-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/aviva-plc-av-gets-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666524741","title":"Beamr to Present at the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666524741","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666524741?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:00","pubTimestamp":1789124400,"startTime":"0","endTime":"0","summary":"Herzliya Israel, Sept.  11, 2026 (GLOBE NEWSWIRE) --  Beamr Imaging Ltd. (Nasdaq: BMR), a leader in video optimization technology and solutions, today announced that it will present virtually at theH.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/11/3360232/0/en/beamr-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","AV","CABR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666976533","title":"Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2666976533","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666976533?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"– FDA authorizes extension of Symvess expiration dating from 18 months to 36 months – – Extended shelf life supported by additional stability data demonstrating Symvess continues to meet all establish","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358551/0/en/humacyte-announces-fda-authorization-extending-symvess-shelf-life-to-36-months.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588","AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796052","title":"Citi Remains a Hold on Aviva plc (AV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796052","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796052?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:35","pubTimestamp":1787733323,"startTime":"0","endTime":"0","summary":"Citi analyst James Shuck maintained a Hold rating on Aviva plc today and set a price target of £7.21. According to TipRanks, Shuck is ranked #703 o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-aviva-plc-av-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-aviva-plc-av-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279504","title":"Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279504","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":"– Supplemental Biologics License Application (BLA) expected to be filed with the Food and Drug Administration (FDA) in November 2026 – – Supplemental BLA will be supported by results from three Phase ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349666/0/en/humacyte-confirms-plans-for-atev-supplemental-bla-filing-for-dialysis-access-following-fda-discussions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127728833","title":"AV Concept Holdings Allocates HK$1.294 Million for Share Buyback on August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1127728833","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127728833?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566093,"startTime":"0","endTime":"0","summary":"AV Concept Holdings (00595) has announced a recent market transaction.According to the company's filing, on August 24, 2026, AV Concept Holdings repurchased 1 million shares of its own stock.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOLD","BK1162","BK1614","AV","00595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260742","title":"Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260742","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260742?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:00","pubTimestamp":1787313600,"startTime":"0","endTime":"0","summary":"ReVeRA-301 Trial is Evaluating the Same 70 mg Repeat-Dose Regimen that is FDA Approved for Paroxysmal Supraventricular Tachycardia (PSVT) Research Builds on Phase 2 Findings that Etripamil 70 mg Dose ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/21/3349033/0/en/milestone-pharmaceuticals-initiates-pivotal-phase-3-trial-of-etripamil-nasal-spray-for-self-administered-treatment-of-atrial-fibrillation-with-rapid-ventricular-rate-afib-rvr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","FXU","VHT","LABU","BK4208","LU0566484027.USD","ECG","ED","LU1559883803.SGD","BK4129","VR","AV","BK4550","LU0170899867.USD","BK4585","LU2346227817.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154204613","title":"Chairman and Executive Director Su Yujun Boosts Stake in AV Concept Holdings with 2.176 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1154204613","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154204613?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:17","pubTimestamp":1787224622,"startTime":"0","endTime":"0","summary":"Hong Kong Exchange filings reveal that on August 14, Chairman and Executive Director Su Yujun increased his shareholding in AV CONCEPT HOLD (00595) by acquiring 2.176 million shares at a price of HKD...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","00595","BK1614","AV","HOLD","BK1162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181238897","title":"AV Concept Holdings Allocates HK$2.58 Million to Buy Back 2 Million Shares on August 20","url":"https://stock-news.laohu8.com/highlight/detail?id=1181238897","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181238897?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:06","pubTimestamp":1787220390,"startTime":"0","endTime":"0","summary":"AV CONCEPT HOLD (00595) has disclosed that on August 20, 2026, the company invested HK$2.5826 million to repurchase 2 million of its own shares.The buyback was executed at a per-share price ranging from HK$1.24 to HK$1.30.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00595","HOLD","BK1162","AV","BK1614"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421176","title":"Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421176","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421176?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:00","pubTimestamp":1787140800,"startTime":"0","endTime":"0","summary":"– Phase 3 results highlight benefits of ATEV for patients at higher risk of fistula failure, including all women and men with obesity and diabetes – – Publication provides peer-reviewed validation for","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347583/0/en/humacyte-announces-lancet-digital-health-publication-of-v007-phase-3-hemodialysis-access-trial-results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660266497","title":"Australian Clinical Labs Leads Our ASX Penny Stock Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660266497","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660266497?lang=en_us&edition=fundamental","pubTime":"2026-08-19 03:02","pubTimestamp":1787079725,"startTime":"0","endTime":"0","summary":"Rising oil prices have recently stirred global markets, impacting sectors across the ASX and contributing to a mixed performance among Australian indices. For investors looking beyond well-known companies, penny stocks—often smaller or newer firms—can present intriguing opportunities despite their somewhat outdated reputation. These stocks can offer a blend of affordability and potential growth when backed by solid financials, making them worth exploring for those seeking unique investment...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-acl/australian-clinical-labs-shares/news/australian-clinical-labs-leads-our-asx-penny-stock-picks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-acl/australian-clinical-labs-shares/news/australian-clinical-labs-leads-our-asx-penny-stock-picks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IIGF.AU","BK7124","GIVE.AU","STW.AU","BK7503","GEAR.AU","XKO.AU","AD8.AU","XJO.AU","QFN.AU","BEAR.AU","ACL.AU","BK7073","QRE.AU","VAS.AU","ZYAU.AU","IISV.AU","BBOZ.AU","VAP.AU","IOZ.AU","AV","IMLC.AU","OZF.AU","DACE.AU","E200.AU","EIGA.AU","OZR.AU","XAO.AU","BK7095","ESR.AU","SLF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660499665","title":"Uber's Expansion with AV Partners Seen Boosting Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2660499665","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660499665?lang=en_us&edition=fundamental","pubTime":"2026-08-19 01:23","pubTimestamp":1787073780,"startTime":"0","endTime":"0","summary":"1322 ET - Mizuho analysts say they see growing evidence that Uber could ultimately benefit from the rise of autonomous vehicles, which they expect to soothe investors' worries of disruption from companies that actually own AV technology. While Waymo has had success in San Francisco that demonstrates strong product-market fit, a broader AV ecosystem is emerging as Uber partners with WeRide, Pony.ai and other AV players, the analysts say. Continued expansion with those non-Waymo partners \"should increase investor confidence that the long-term AV ecosystem is likely to support multiple suppliers rather than a winner-take-all outcome,\" the analysts say. While diversification may take time, operational data points \"reinforce our view AV adoption can expand the overall category without necessarily undermining Uber's platform position,\" they say.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","BK4551","SG9999018865.SGD","SG9999015986.USD","BK4230","BK4550","LU2237957902.USD","BK4505","SG9999018857.SGD","SGXZ31699556.SGD","SG9999015952.SGD","LU0552385451.USD","LU1988902786.USD","UBEW","WNDR","LU2237957811.SGD","IE0002270589.USD","LU0006306889.USD","LU1861219969.SGD","TPOR","BK4585","UBER","LU0082616367.USD","LU0719512351.SGD","BK4535","GB00BDT5M118.USD","IE00BZ199S13.USD","LU2264538146.SGD","BK4503","FDRV","BK4536","IYT","SG9999015978.USD","UBRL","SG9999014906.USD","SGXZ81514606.USD","LU0106261372.USD","SG9999017495.SGD","LU2087625088.SGD","IE00BFMHRM44.USD","LU0127658192.USD","LU0353189763.USD","BK4588","LU1814569148.SGD","SGXZ99366536.SGD","AV","LU0353189680.USD","LU1316542783.SGD","IE00B19Z3581.USD","LU0107464264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660629464","title":"Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”","url":"https://stock-news.laohu8.com/highlight/detail?id=2660629464","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660629464?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:00","pubTimestamp":1787054400,"startTime":"0","endTime":"0","summary":"– Jeromy Brink, MD, Mayo Clinic–trained vascular surgeon in Phoenix, is the first surgeon in Arizona to implant Symvess, the first and only FDA-approved bioengineered human blood vessel – – Symvess is","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/18/3346750/0/en/board-certified-vascular-and-endovascular-surgeon-performs-first-commercial-symvess-implantation-cites-bioengineered-blood-vessel-as-revolutionary-advancement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908917","title":"Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908917","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908917?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:08","pubTimestamp":1786532880,"startTime":"0","endTime":"0","summary":"Over 50% of commercially insured lives in the U.S., representing a recent and significant increase, now have coverage for CARDAMYST (etripamil) nasal spray Phase 3 registrational trial of etripamil fo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343531/0/en/milestone-pharmaceuticals-announces-second-quarter-2026-financial-results-and-provides-corporate-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","ECG","EMA","AV","LU0566484027.USD","BK4129","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658044979","title":"Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658044979","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658044979?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532400,"startTime":"0","endTime":"0","summary":"-- Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","LABU","SPRE","BK4215","BK4167","BK4139","CTEV","R","MAA","AV","BK4588","HUMA","BK4022","BK4585","IND","BK4563"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":86,"code":"91000000","status":"200"}]}}